Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masuzawa

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Digestive Diseases and Sciences|May 1, 1996
Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis CH Hagiwara, N Hayashi, A Kasahara, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|June 19, 2010
Efficacy of selective transarterial chemotherapy using a port systemfor angiosarcomas of the face and scalpK Iwamoto, S Suzuki, A Kurata, et al.
Journal of Clinical Gastroenterology|March 24, 2000
Reappraisal of biochemical hepatitis C activity in hemodialysis patientsN Yuki, H Ishida, T Inoue, et al.
Journal of Medical Virology|October 27, 1999
Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysisN Yuki, M Kato, M Masuzawa, et al.
Journal of Medical Virology|May 23, 1998
GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapyM Oshita, N Hayashi, E Mita, et al.
The Review of Scientific Instruments|April 6, 2021
Systematic evaluation of magnetic sensitivities of anisotropic magnetoresistive sensors at liquid helium temperature for superconducting cavitiesT Okada, E Kako, T Konomi, et al.
Oncogenesis|September 18, 2013
Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivoM Hashimoto, F Suizu, W Tokuyama, et al.
Journal of Gastroenterology and Hepatology|October 12, 2001
Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic responseK Ohkawa, N Hiramatsu, K Mochizuki, et al.
Journal of Clinical Gastroenterology|December 29, 2000
Retreatment with interferon for chronic hepatitis C after transient responseK Iyoda, N Yuki, M Kato, et al.
International Journal of Cancer|August 5, 2000
Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patientsH Tanaka, H Tsukuma, A Kasahara, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Digestive Diseases and Sciences|May 1, 1996
Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis CH Hagiwara, N Hayashi, A Kasahara, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|June 19, 2010
Efficacy of selective transarterial chemotherapy using a port systemfor angiosarcomas of the face and scalpK Iwamoto, S Suzuki, A Kurata, et al.
Journal of Clinical Gastroenterology|March 24, 2000
Reappraisal of biochemical hepatitis C activity in hemodialysis patientsN Yuki, H Ishida, T Inoue, et al.
Journal of Medical Virology|October 27, 1999
Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysisN Yuki, M Kato, M Masuzawa, et al.
Journal of Medical Virology|May 23, 1998
GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapyM Oshita, N Hayashi, E Mita, et al.
The Review of Scientific Instruments|April 6, 2021
Systematic evaluation of magnetic sensitivities of anisotropic magnetoresistive sensors at liquid helium temperature for superconducting cavitiesT Okada, E Kako, T Konomi, et al.
Oncogenesis|September 18, 2013
Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivoM Hashimoto, F Suizu, W Tokuyama, et al.
Journal of Gastroenterology and Hepatology|October 12, 2001
Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic responseK Ohkawa, N Hiramatsu, K Mochizuki, et al.
Journal of Clinical Gastroenterology|December 29, 2000
Retreatment with interferon for chronic hepatitis C after transient responseK Iyoda, N Yuki, M Kato, et al.
International Journal of Cancer|August 5, 2000
Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patientsH Tanaka, H Tsukuma, A Kasahara, et al.
Pageof 11